More than Half of Health Care Industry Execs Expect 340B Reporting Requirements Within Five Years

More than half (55 percent) of 130 health care industry C-suite executives surveyed expect that reporting requirements and other restrictions will be attached to the 340B program within the next five years, a health care consulting firm’s latest survey of industry executives shows. Just under half (48 percent) of the executives said an anticipated further cut in what Medicare Part B pays hospitals for 340B purchased drugs is one of the proposed regulatory changes that impacts their strategy planning most.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

*Sign up for news summaries and alerts from 340B Report